Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosis

BACKGROUND: To explore the prognostic value of serial dynamic contrast-enhanced (DCE) MRI in patients with advanced pulmonary adenocarcinoma undergoing first-line therapy with either tyrosine-kinase inhibitors (TKI) or platinum-based chemotherapy (PBC). METHODS: Patients underwent baseline (day 0, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Rheinheimer, Stephan, Christopoulos, Petros, Erdmann, Stella, Saupe, Julia, Golpon, Heiko, Vogel-Claussen, Jens, Dinkel, Julien, Thomas, Michael, Heussel, Claus Peter, Kauczor, Hans-Ulrich, Heussel, Gudula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724354/
https://www.ncbi.nlm.nih.gov/pubmed/36471318
http://dx.doi.org/10.1186/s12880-022-00943-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724354/
https://www.ncbi.nlm.nih.gov/pubmed/36471318
http://dx.doi.org/10.1186/s12880-022-00943-x

Ejemplares similares